Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute cardiometabolic risks during haloperidol treatment in elderly patients
NL-OMON21267Suspended
- Sponsor
- Tergooi MC
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of haloperidol in delirium, sponsored by Tergooi MC. Primary endpoints: QTc prolongation by Holter ECG, Cardiometabolic serum markers and 1 more. Started Dec 2012; status: suspended.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON21267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21267.